Literature DB >> 6450219

Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection.

P C Rubin, J Brunton, P Meredith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6450219     DOI: 10.1016/s0378-4347(00)81025-7

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  18 in total

1.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

2.  Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.

Authors:  M Chung; V Vashi; J Puente; M Sweeney; P Meredith
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

3.  Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans.

Authors:  K Harada; M Ohmori; A Fujimura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.

Authors:  R M Oliver; J W Upward; A G Dewhurst; R Honeywell; A G Renwick; D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

5.  A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients.

Authors:  P J Scott; J Hosie; M G Scott
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  The pharmacokinetics of doxazosin in elderly normotensives.

Authors:  J Vincent; P A Meredith; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

7.  Clinical pharmacological studies with doxazosin.

Authors:  H L Elliott; P A Meredith; J Vincent; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

8.  The pharmacodynamics and pharmacokinetics of the combination of nifedipine and doxazosin.

Authors:  R Donnelly; H L Elliott; P A Meredith; C A Howie; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

10.  A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

Authors:  H L Elliott; P A Meredith; D J Sumner; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.